Why do patients with diffuse large B-cell lymphoma (DLBCL) — the most common form of non-Hodgkin's lymphoma — have such a variable response to chemotherapy? Eric Davis and colleagues now provide a ...

Regarding the articles on microarrays, 1-3 Pat Brown and the group at Stanford deserve great recognition for their technological innovations that led to widespread use of microarray analysis in ...

A recent study highlights how DNA microarray technology enables high-throughput gene analysis, supporting variation detection, expression profiling, and clinical research. By refining probe design and ...